CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 98 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2018. The put-call ratio across all filers is 0.96 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | -60.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | -78.3% | 10,000 | 0.0% | 0.00% | – |
| Q1 2018 | $23,000 | -17.9% | 10,000 | 0.0% | 0.00% | – |
| Q4 2017 | $28,000 | -3.4% | 10,000 | 0.0% | 0.00% | – |
| Q3 2017 | $29,000 | +16.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2017 | $25,000 | -30.6% | 10,000 | 0.0% | 0.00% | – |
| Q1 2017 | $36,000 | +2.9% | 10,000 | 0.0% | 0.00% | – |
| Q4 2016 | $35,000 | -12.5% | 10,000 | 0.0% | 0.00% | – |
| Q3 2016 | $40,000 | -54.5% | 10,000 | -50.0% | 0.00% | -100.0% |
| Q2 2016 | $88,000 | +131.6% | 20,000 | +100.0% | 0.00% | 0.0% |
| Q1 2016 | $38,000 | -96.7% | 10,000 | -86.4% | 0.00% | -93.8% |
| Q4 2015 | $1,151,000 | +130.2% | 73,400 | +54.9% | 0.02% | +128.6% |
| Q3 2015 | $500,000 | -59.1% | 47,400 | -2.3% | 0.01% | -50.0% |
| Q2 2015 | $1,223,000 | -7.6% | 48,500 | +2.1% | 0.01% | -12.5% |
| Q1 2015 | $1,324,000 | +93.6% | 47,500 | +26.7% | 0.02% | +128.6% |
| Q4 2014 | $684,000 | +83.4% | 37,500 | +30.2% | 0.01% | +75.0% |
| Q3 2014 | $373,000 | -32.1% | 28,800 | -14.4% | 0.00% | -20.0% |
| Q2 2014 | $549,000 | -37.7% | 33,650 | -32.5% | 0.01% | -58.3% |
| Q1 2014 | $881,000 | -22.3% | 49,850 | +6.4% | 0.01% | -20.0% |
| Q4 2013 | $1,134,000 | +26.0% | 46,850 | +84.4% | 0.02% | +36.4% |
| Q3 2013 | $900,000 | +179.5% | 25,400 | +23.3% | 0.01% | +175.0% |
| Q2 2013 | $322,000 | – | 20,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |